SwissDock, a protein-small molecule docking web service based on EADock DSS

Nucleic Acids Research

Volumn 39, Issue SUPPL. 2, 2011, Pages

  Grosdidier, Aurélien ^a   Zoete, Vincent ^a   Michielin, Olivier ^a,b  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOINFORMATICS; COMPUTER INTERFACE; COMPUTER PROGRAM; INTERNET; LIGAND BINDING; MOLECULAR DOCKING; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN TARGETING; WEB BROWSER;

DRUG DESIGN; INTERNET; LIGANDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN ENGINEERING; SOFTWARE;

EID: 79960029361     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr366     Document Type: Article

References (35)

1. Looger, L.L., Dwyer, M.A., Smith, J.J. and Hellinga, H.W. (2003) Computational design of receptor and sensor proteins with novel functions. Nature, 423, 132-133.
2. Röthlisberger, D., Khersonsky, O., Wollacott, A.M., Jiang, L., DeChancie, J., Betker, J., Gallaher, J.L., Althoff, E.A., Zanghellini, A., Dym, O. et al. (2008) Kemp elimination catalysts by computational enzyme design. Nature, 453, 190-195. (Pubitemid 351667979)
3. Boehm, H.J., Boehringer, M., Bur, D., Gmuender, H., Huber, W., Klaus, W., Kostrewa, D., Kuehne, H., Luebbers, T., Meunier- Keller, N. et al. (2000) Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. J. Med. Chem., 43, 2664-2674. (Pubitemid 30463915)
4. Shoichet, B.K., McGovern, S.L., Wei, B. and Irwin, J.J. (2002) Lead discovery using molecular docking. Curr. Opin. Chem. Biol., 6, 439-446. (Pubitemid 34808727)
5. Blake, J.F. and Laird, E.R. (2003) Chapter 30. Recent advances in virtual ligand screening. Annu. Rep. Med. Chem., 38, 305-314. (Pubitemid 137639431)
6. Doman, T.N., McGovern, S.L., Witherbee, B.J., Kasten, T.P., Kurumbail, R., Stallings, W.C., Connolly, D.T. and Shoichet, B.K. (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J. Med. Chem., 45, 2213-2221. (Pubitemid 34525801)
7. Paiva, A.M., Vanderwall, D.E., Blanchard, J.S., Kozarich, J.W., Williamson, J.M. and Kelly, T.M. (2001) Inhibitors of dihydrodipicolinate reductase, a key enzyme of the diaminopimelate pathway of Mycobacterium tuberculosis. Biochim. Biophys. Acta, 1545, 67-77. (Pubitemid 32124808)
8. Röhrig, U.F., Awad, L., Grosdidier, A., Larrieu, P., Stroobant, V., Colau, D., Cerundolo, V., Simpson, A.J., Vogel, P., Van den Eynde, B.J. et al. (2010) Rational design of indoleamine 2,3-dioxygenase inhibitors. J. Med. Chem., 53, 1172-1189.
9. Huang, D., Lüthi, U., Kolb, P., Cecchini, M., Barberis, A. and Caflisch, A. (2006) In silico discovery of beta-secretase inhibitors. J. Am. Chem. Soc., 128, 5436-5443.
10. Cai, J., Han, C., Hu, T., Zhang, J., Wu, D., Wang, F., Liu, Y., Ding, J., Chen, K., Yue, J. et al. (2006) Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci., 15, 2071-2081. (Pubitemid 44316010)
11. Michalik, L., Zoete, V., Krey, G., Grosdidier, A., Gelman, L., Chodanowski, P., Feige, J.N., Desvergne, B., Wahli, W. and Michielin, O. (2007) Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior. J. Biol. Chem., 282, 9666-9677. (Pubitemid 47104582)
12. Huang, D. and Caflisch, A. (2004) Efficient evaluation of binding free energy using continuum electrostatics solvation. J. Med. Chem., 47, 5791-5797. (Pubitemid 39447274)
13. Huang, D., Lüthi, U., Kolb, P., Edler, K., Cecchini, M., Audetat, S., Barberis, A. and Caflisch, A. (2005) Discovery of cell-permeable non-peptide inhibitors of beta-secretase by high-throughput docking and continuum electrostatics calculations. J. Med. Chem., 48, 5108-5111. (Pubitemid 41113898)
14. Jorgensen, W.L. (2004) The many roles of computation in drug discovery. Science, 303, 1813-1818. (Pubitemid 38374866)
15. Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E. (2000) The Protein Data Bank. Nucleic Acids Res., 28, 235-242. (Pubitemid 30047768)
16. Davis, A.M., St Gallay, S.A. and Kleywegt, G.J. (2008) Limitations and lessons in the use of X-ray structural information in drug design. Drug Discov. Today, 831-841.
17. Kolb, P. and Irwin, J.J. (2009) Docking screens: right for the right reasons? Curr. Top Med. Chem., 9, 755-770.
18. Irwin, J.J., Shoichet, B.K., Mysingery, M.M., Huang, N., Colizzi, F., Wassam, P. and Cao, Y. (2009) Automated docking screens: a feasibility study. J. Med. Chem., 52, 5712-5720.
19. Zoete, V.F., Cuendet, M., Grosdidier, A. and Michielin, O. (2011) SwissParam: A fast force field generation tool for small organic molecules. J. Comput. Chem., May 3 (doi:10.1002/jcc.21816; epub ahead of print).
20. Grosdidier, A., Zoete, V. and Michielin, O. (2011) Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem., May 3 (doi:10.1002/jcc.21797; epub ahead of print).
21. Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C. and Ferrin, T.E. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem., 13, 1605-1612.
22. Grosdidier, A., Zoete, V. and Michielin, O. (2009) Blind docking of 260 protein-ligand complexes with EADock 2.0. J. Comput. Chem., 13, 2021-2030.
23. Irwin, J.J. and Shoichet, B.K. (2005) ZINC-a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model., 45, 177-182. (Pubitemid 40736970)
24. Jmol: an Open-Source Java Viewer for Chemical Structures in 3D, http://wwwjmol.org/ (October 2010, date last accessed).
25. Roche, O., Kiyama, R. and Brooks, C.L. III (2001) Ligand-protein database: linking protein-ligand complex structures to binding data. J. Med. Chem., 44, 3592-3598. (Pubitemid 33026666)
26. Brooks, B.R., Brooks, C.L. III, Mackerell, A.D. Jr, Nilsson, L., Petrella, R.J., Roux, B., Won, Y., Archontis, G., Bartels, C., Boresch, S. et al. (2009) CHARMM: the biomolecular simulation program. J. Comput. Chem., 30, 1545-1614.
27. Haberthür, U. and Caflisch, A. (2008) FACTS: fast analytical continuum treatment of solvation. J. Comput. Chem., 29, 701-715. (Pubitemid 351364845)
28. Halgren, T.A. (1996) Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem., 17, 490-519. (Pubitemid 126567067)
29. Halgren, T.A. (1996) Merck molecular force field. II. MMFF94 van der Waals and electrostatic parameters for intermolecular interactions. J. Comput. Chem., 17, 520-552. (Pubitemid 126567068)
30. Halgren, T.A. (1996) Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94. J. Comput. Chem., 17, 553-586. (Pubitemid 126567069)
31. Halgren, T.A. (1996) Merck molecular force field. IV. Conformational energies and geometries for MMFF94. J. Comput. Chem., 17, 587-615. (Pubitemid 126567070)
32. Halgren, T.A. (1996) Merck molecular force field. V. Extension of MMFF94 using experimental data, additional computational data, and empirical rules. J. Comput. Chem., 17, 616-641. (Pubitemid 126567071)
33. Guha, R., Howard, M.T., Hutchison, G.R., Murray-Rust, P., Rzepa, H., Steinbeck, C., Wegner, J. and Willighagen, E.L. (2006) The Blue Obelisk-interoperability in chemical informatics. J. Chem. Inf. Model., 46, 991-998.
34. Mills, N. (2006) ChemDraw Ultra 10.0. J. Am. Chem. Soc., 128, 13649-13650.
35. Onken, M.D., Worley, L.A., Long, M.D., Duan, S., Council, M.L., Bowcock, A.M. and Harbour, J.W. (2008) Oncogenic mutations in GNAQ occur early in uveal melanoma. Invest. Ophthalmol. Vis. Sci., 49, 5230-5234.